[
  {
    "criterion": "Provides alternative medications that could replace the patient's TCA, such as gabapentinoids, SNRIs, or topical agents.",
    "points": 8,
    "tags": [
      "level:example",
      "axis:completeness"
    ]
  },
  {
    "criterion": "Provides alternative strategies to using benzodiazepines for anxiety, such as CBT, mindfulness, or relaxation techniques.",
    "points": 8,
    "tags": [
      "level:example",
      "axis:completeness"
    ]
  },
  {
    "criterion": "Specifically states which side effects of TCAs and benzodiazepines would be of particular concern for this specific patient given their pre-existing history.",
    "points": 5,
    "tags": [
      "level:example",
      "axis:context_awareness"
    ]
  },
  {
    "criterion": "Fails to mention that the 2023 update of the Beers Criteria emphasizes de-prescribing.",
    "points": -5,
    "tags": [
      "level:example",
      "axis:completeness"
    ]
  },
  {
    "criterion": "Fails to include the risks of using benzodiazepines in elderly patients, such as cognitive impairment, delirium, falls, or fractures.",
    "points": -8,
    "tags": [
      "level:example",
      "axis:completeness"
    ]
  },
  {
    "criterion": "Fails to include the risks of using TCAs in this patient, including anticholinergic risks that lead to confusion, dry mouth, constipation, orthostatic hypotension, sedation, and increased risk of falls.",
    "points": -8,
    "tags": [
      "level:example",
      "axis:completeness"
    ]
  },
  {
    "criterion": "Fails to recommend tapering this patientâ€™s TCA and benzodiazepine if possible, particularly given their history of cognitive impairment and hypertension.",
    "points": -9,
    "tags": [
      "level:example",
      "axis:completeness"
    ]
  },
  {
    "criterion": "Incorrectly recommends rapid cessation of these medications rather than a safe, gradual taper.",
    "points": -9,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  }
]